Akademisyen
ARZU ZEYNEP KARABAY
PROFESÖR
ANKARA ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ TEMEL ECZACILIK BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Biyokimya
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 57
- Proje 0
- Kitap 4
- Bildiri 30
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
13
Q2
20
Q3
10
Q4
3
WoS (JCR)
Q1
8
Q2
6
Q3
20
Q4
8
TR Index
3
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
2
Üst %10 makale
7
Ort. yüzdelik
58.6%
Üst %1 payı
3.9%
Üst %10 payı
13.7%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Synthesis, characterization and biological activity of metal nanoparticles with green method using apple industry waste YÖKSİS SJR Q1 JCR Q1 OpenAlex 13.2%
- 2025 Multifaceted Therapeutic Potential of Plant-Derived Exosomes: Immunomodulation, Anticancer, Anti-Aging, Anti-Melanogenesis, Detoxification, and Drug Delivery YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %1 OpenAlex 99.7%
- 2025 Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells YÖKSİS SJR Q1 JCR Q1 OpenAlex 24.3%
- 2024 Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemia YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 90.4%
- 2024 Methylsulfonylmethane induces caspase-dependent apoptosis in acute myeloid leukemia cell lines YÖKSİS SJR Q2 JCR Q3 OpenAlex 84.1%
- 2024 Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.9%
- 2023 Phenotypic and functional characterization of subpopulation of Imatinib resistant chronic myeloid leukemia cell line YÖKSİS SJR Q2 JCR Q3 OpenAlex 74.2%
- 2023 Novel indole retinoid derivative induces apoptosis and cell cycle arrest and modulates AKT and ERK signaling in HL‐60 cells YÖKSİS SJR Q2 JCR Q3 OpenAlex 44.3%
- 2023 KOENZİM Q0 İNSAN KRONİK MYELOİD LÖSEMİ K562 HÜCRELERİNİN PROLİFERASYONUNU ENGELLER VE MAPK VE AKT SİNYAL YOLAKLARINI MODÜLE EDER YÖKSİS SJR Q3 OpenAlex 49.9%
- 2023 Effects of trazodone on viability in healthy and malignant ovarian cells YÖKSİS OpenAlex 14.2%
- 2022 AN INVESTIGATION ON THE EFFECTS OF SIRT5 MODULATORS ON SIRT5 AND CYTOCHROME C PROTEIN EXPRESSIONS IN K562 CHRONIC MYELOID LEUKEMIA CELL LINE YÖKSİS SJR Q4 OpenAlex 13.6%
- 2022 CYTOTOXIC AND ANTIOXIDANT ACTIVITIES OF ALCHEMILLA MOLLIS (BUSER) ROTHM. AND ITS CONTITUENTS; HYPEROSIDE AND ISOQUERCETIN YÖKSİS SJR Q4 OpenAlex 31.7%
- 2022 Time and Concentration Dependent Effects of Different Solvents on Proliferation of K562, HL60, HCT-116 and H929 Cell Lines YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 66.0%
- 2021 Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 92.7%
- 2021 EFFECTS OF PROBUCOL ON CELL PROLIFERATION IN LEUKEMIA, MULTIPLE MYELOMA, LYMPHOMA AND FIBROBLAST CELL LINES YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 19.1%
- 2021 Synthesis and Cytotoxicity of Some Imidazo[4,5-b]pyridine Derivatives and Their Regioselective N-Alkylation YÖKSİS SJR Q2 JCR Q3 OpenAlex 62.0%
- 2020 Regioselective N-alkylation of some imidazole-containing heterocycles and their in vitro anticancer evaluation YÖKSİS SJR Q2 JCR Q3 OpenAlex 64.7%
- 2020 Synthesis of Some Benzimidazole-derived Molecules and their Effects on PARP-1 Activity and MDA-MB-231, MDA-MB-436, MDA-MB-468 Breast Cancer Cell Viability YÖKSİS SJR Q3 JCR Q3 OpenAlex 65.4%
- 2018 Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia YÖKSİS SJR Q3 JCR Q4 OpenAlex 75.4%
- 2018 Apoptotic Effects of Some Tetrahydronaphthalene Derivatives on K562 Human Chronic Myelogenous Leukemia Cell Line YÖKSİS SJR Q2 JCR Q3 OpenAlex 56.4%